Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Pfaff

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2020
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma PatientsOana C Kulterer, Sarah Pfaff, Wolfgang Wadsak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2019
Prospective evaluation of the performance of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomyMohammad Abufaraj, Bernhard Grubmüller, Markus Zeitlinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2018
Response assessment using <sup>68</sup>Ga-PSMA ligand PET in patients undergoing <sup>177</sup>Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Daniela Senn, Gero Kramer, et al.
Nuclear Medicine and Biology|November 1, 2018
Molar activity - The keystone in <sup>11</sup>C-radiochemistry: An explorative study using the gas phase methodVerena Pichler, Thomas Zenz, Cécile Philippe, et al.
Theranostics|January 4, 2021
CXCR4 PET imaging of mantle cell lymphoma using [<sup>68</sup>Ga]Pentixafor: comparison with [<sup>18</sup>F]FDG-PETMarius E Mayerhoefer, Markus Raderer, Wolfgang Lamm, et al.
The Prostate|October 16, 2019
Response assessment using [<sup>68</sup> Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Sazan Rasul, Pascal Baltzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2018
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical ImpactBernhard Grubmüller, Pascal Baltzer, Sabrina Hartenbach, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2020
A Microdosing Study with <sup>99m</sup>Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma PatientsOana C Kulterer, Sarah Pfaff, Wolfgang Wadsak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2019
Prospective evaluation of the performance of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomyMohammad Abufaraj, Bernhard Grubmüller, Markus Zeitlinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2018
Response assessment using <sup>68</sup>Ga-PSMA ligand PET in patients undergoing <sup>177</sup>Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Daniela Senn, Gero Kramer, et al.
Nuclear Medicine and Biology|November 1, 2018
Molar activity - The keystone in <sup>11</sup>C-radiochemistry: An explorative study using the gas phase methodVerena Pichler, Thomas Zenz, Cécile Philippe, et al.
Theranostics|January 4, 2021
CXCR4 PET imaging of mantle cell lymphoma using [<sup>68</sup>Ga]Pentixafor: comparison with [<sup>18</sup>F]FDG-PETMarius E Mayerhoefer, Markus Raderer, Wolfgang Lamm, et al.
The Prostate|October 16, 2019
Response assessment using [<sup>68</sup> Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Sazan Rasul, Pascal Baltzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2018
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical ImpactBernhard Grubmüller, Pascal Baltzer, Sabrina Hartenbach, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
Pageof 2